DNA X, Inc.
SONM- Exchange
- Nasdaq
- Industry
- Telephone & Telegraph Apparatus
- SEC CIK
- 0001178697
No open-market purchases or sales by DNA X, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $453.8K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding DNA X, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 29 | 21 | −8 |
| Shares | 21.1M | 14.4M | −6.75M (−32.0%) |
| Value | $17.3M | $8.04M | −$9.28M (−53.6%) |
New holders (3)
Institutions that held DNA X, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 72,458 | $40.0K | 0.00% |
| Equitec Proprietary Markets, LLC | 15,300 | $9.00K | 0.01% |
| Emfo, LLC | 2,000 | $1.00K | 0.00% |
Sold out (11)
Institutions that held DNA X, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Perkins Capital Management Inc | 1,819,567 | $1.49M |
| Harvey Partners, LLC | 1,529,000 | $1.25M |
| Manatuck Hill Partners, LLC | 1,394,000 | $1.14M |
| Union Square Park Capital Management, LLC | 1,000,000 | $820.0K |
| Squarepoint Ops LLC | 365,024 | $299.0K |
| Bank of New York Mellon Corp | 143,466 | $118.0K |
| Goldman Sachs Group Inc | 70,436 | $58.0K |
| Bridgeway Capital Management, LLC | 43,900 | $36.0K |
| UBS Group AG | 10,725 | $9.00K |
| Royal Bank of Canada | 5,000 | $4.00K |
| Tower Research Capital LLC (TRC) | 293 | $0 |